natap.org Pokaż na alexa.com natap.org
Przekieruj do natap.orgusuń
National AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information
Pozycja lokalna
374 097
374 097
Pozycja globalna
765 491
Society » Issues » Health » Conditions and Diseases » Sexually Transmitted Diseases » AIDS » Treatment Activism » Organizations
Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Regional » North America » United States » New York
Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Treatment and Therapies
United States » Society » Issues » Health » Conditions and Diseases » Sexually Transmitted Diseases » AIDS » Treatment Activism » Organizations
United States » Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Regional » North America » United States » New York
United States » Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Treatment and Therapies
-
-
Dziennie unikalnych użytkowników 764Dziennie unikalnych wyświetleń 993
- Obserwuj
-
Średni czas ładowania się strony brakAdres IP 216.92.100.202Czas ostatniej aktualizacji 12 roku temu
-
Ranking Alexa z ostatniego miesiąca (top 1m)
Wykres z ostatnich 30 dni Wykres z ostatnich 3 miesięcy Wykres z ostatnich 6 miesięcy Wykres z ostatniego rokuPorównaj natap.org do:
-
Strony wejścia na natap.org
google.com 39.13% -
Strony wyjścia z natap.org
google.com 38.10% -
Stron zaindeksowanych w
Yahoo 35Bing 33 -
Linki zwrotne
Yahoo brakBing brakAlexa 626 -
Media społecznościowe
Facebook 47Twitter 17 -
Informacje o stronie
TytułNational AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information
OpisNatap's web site is a leader in up-to-the minute HIV treatment information, covering the latest in drug development and research, comprehensive conference reports, and in-depth articles on HIV treatments. NATAP's newsletter, Protease Inhibitor User's Guide, and other publications are all available on the site
Słowa kluczoweprotease inhibitors, HIV, AIDS, treatment, Hep C, hepatitis, Hepatitis C, HCV, coinfection, co-infection, IVDU, peg-intron, Interferon, liver, Ribavirin, Pegylated Interferon, Pegasys, genotype, experimental, nucleosides, non-nucleosides, drug therapies, HIV drugs, adherence, compliance, viral load, 50 copies, proviral DNA, RNA, 4 drugs, Efavirenz, DMP-266, salvage therapy, 1592U89, Abacavir, t-20, fusion inhibitor, PMEA, MKC-442, resistance, double protease, Crixivan, indinavir, Viracept, nelfi